In a time of increasingly bespoke healthcare, Elizabeth Philp has emerged as a significant force of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a drive to make custom medications more obtainable, disrupting the conventional one-size-fits-